Do you want to skip to content? Skip to content
Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))
False /oidc-signin/en-gb/ Convatec Group Contact Us Brasil Brasil United States (English) United States (English) Estados Unidos (Español) Estados Unidos (Español) Argentina Argentina Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Ecuador Ecuador México México Perú Perú Belize Belize Guyana Guyana Jamaica Jamaica Venezuela Venezuela Costa Rica Costa Rica Curaçao Curaçao República Dominicana República Dominicana Guatemala Guatemala Honduras Honduras Nicaragua Nicaragua Panamá Panamá Puerto Rico Puerto Rico Suriname Suriname El Salvador El Salvador United Kingdom United Kingdom France France Deutschland Deutschland Italia Italia Україна Україна België België Česko Česko Danmark Danmark España España Ireland Ireland Nederland Nederland Norge Norge Österreich Österreich Polska Polska Schweiz (Deutsch) Schweiz (Deutsch) Slovensko Slovensko Suisse (Français) Suisse (Français) Suomi Suomi Sverige Sverige Türkiye Türkiye Ελλάδα Ελλάδα Россия Россия Bosna i Hercegovina Bosna i Hercegovina България България Eesti Eesti Hrvatska Hrvatska Magyarország Magyarország Ísland Ísland Lietuva Lietuva Latvija Latvija Северна Македонија Северна Македонија Malta Malta România România Srbija Srbija Slovenija Slovenija الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين مصر مصر ישראל ישראל ایران ایران الأردن الأردن عُمان عُمان قطر قطر پاکستان پاکستان لبنان لبنان الكويت الكويت المملكة العربية السعودية المملكة العربية السعودية Suid-Afrika Suid-Afrika العراق العراق New Zealand New Zealand 日本 日本 Australia Australia India India Malaysia Malaysia Singapore Singapore 대한민국 대한민국 中国大陆 中国大陆 中国台湾 中国台湾 ไทย ไทย Indonesia Indonesia Việt Nam Việt Nam Philippines Philippines Hong Kong SAR China (English) Hong Kong SAR China (English) 中国香港特别行政区 (中文(简体,中国香港特别行政区)) 中国香港特别行政区 (中文(简体,中国香港特别行政区))

ChloraSolv®

Convenient, effective & gentle debridement of
lower leg and diabetic foot ulcers
Order Sample Book appointment
ChloraSolv® Wound Debridement Kit ; ChloraSolv® - Syringe ;

ChloraSolv® Wound Debridement Gel

ChloraSolv® Wound Debridement Gel is a new and unique technology indicated for patients with lower leg and diabetic foot ulcers.

ChloraSolv® is based on a unique hypochlorite technology consisting of a two-component system.1

Download our product guide

ChloraSolv® brings unique benefits for wound debridement

ChloraSolv® product photo, showing a box of gel and a syringe. ;

Easy to use in primary care settings and in patients’ homes by all healthcare professionals

Makes it easy to mechanically remove devitalised tissue, biofilm, pus and dirt with a blunt instrument and/or washing and wiping off the wound bed2

Short application time and fast acting to enable an efficient cleaning procedure3

Facilitates cleansing and debridement of hard-to-heal wounds4, preserving healthy, viable tissue2

Softens the necrotic tissue of hard-to-heal lower leg and diabetic foot ulcers, for gentler and easier wound debridement3,5

Contains sodium hypochlorite - a broad-spectrum anti-microbiological agent that reduces the microbiological load6

Reduces pain related to debridement in patients with hard-to-heal lower extremities and diabetic foot ulcers3

Preserves healthy, granulating and viable tissue during debridement2

ChloraSolv® is non-irritant2

Illustration of the Wound Debridement Process that includes cleaning, Debriding, Refashioning and dressing ;

The importance of debridement – Introducing a new Chemo mechanical technology

Debridement of devitalised tissue and wound biofilm are vital to promote healing.

This peer-reviewed article introduces ChloraSolv Wound Debridement Gel, its innovative technology, its advantages versus other debridement options and six clinical cases and Q&A interview with leading TVN and podiatrist experts.7

Download

Find out more about the application steps of ChloraSolv®

Discover now
Illustration of ChloraSolv® application steps on a wound ;
  1. Take the double syringe out of the aluminium pouch. Hold the syringe with the opening upwards and remove the cap. Keep the syringe upright and mount the brown mixer element. Apply the plunger in the two barrels.
  2. Press the plunger downwards and apply a thin layer of the mixed gel directly to the wound bed. The gel should cover the wound completely when applied.
  3. Leave the gel on the wound for 2-5 minutes.
  4. Remove loosened necrotic tissue, using a gentle scraping action with a blunt instrument.
  5. Rinse the wound area with water or isotonic saline solution and wipe dry.
  6. Finish the procedure with a second application of the gel directly onto the wound area to completely clean the wound bed. The product should cover the wound area completely when applied.
  7. Leave the gel on the wound for 2-5 minutes.
  8. Remove loosened necrotic tissue, using a gentle scraping action with a blunt instrument.
  9. Rinse the wound area with water or isotonic saline solution and wipe dry.
  10. Protect the wound with a bandage or dressing appropriate for the state of the wound.

Clinical Evidence

ChloraSolv® is effective and can be used in conjunction with weekly dressings to improve healing of diabetic foot ulcers compared with current standard treatment (advanced wound dressing and sharp debridement)⁸

ChloraSolv® demonstrated statistically significant differences vs standard of care
A visual representation of ChloraSolv® foot ulcer reduction in 5 weeks ; Comparison of ulcer size reduction between standard treatment and ChloraSolv® group, showing faster results with ChloraSolv® ;

ChloraSolv® can be effective and is well-tolerated in the treatment of hard-to-heal wounds to soften and remove devitalised tissue3

Comparison of devitalized tissue reduction with wound size at 5 weeks ;

Mechanism of Action

A screenshot of a video on the Convatec website showing Dr. Daniel Metcalf discussing the ChloraSolv® mechanism. ;

Overall experience rated good or very good by 100% of respondents3

Patients' ratings about their debridement experience with ChloraSolv® Patients' ratings about their debridement experience with ChloraSolv®
Illustration of the Wound Debridement process ;

ChloraSolv® Wound Debridement Gel White Paper

Read our new White Paper highlighting the importance of effective debridement in managing hard-to-heal wounds. Understanding how ChloraSolv® can improve outcomes for your patients with hard-to-heal leg ulcers and diabetic foot ulcers and address the need for easy to use, fast and effective debridement solution like ChloraSolv®.9

ChloraSolv® effectively eradicates biofilm bacteria in just 2 minutes*6

*In-vitro
Download the publication

Case study

Female
Diabetic ulcer
55 years old
Duration +2 years
Planned amputation
Comparison of wound debridement before and after treatment, assessed between 23rd March 2020 and 9th April 2020 ; Comparison of wound debridement before and after treatment, assessed between 1st June 2020 and 27th July 2020 ;

Ordering information

Brand Description Pack Size Product Code
ChloraSolv® Wound debridement gel 5 423567

 

For more info visit the legal manufacturer’s (RLS Global AB) website at www.chlorasolvacademy.se

ChloraSolv® is manufactured by RLS Global AB and exclusively distributed by Convatec in Europe.© RLS Global AB. ChloraSolv® and the RLS logo are trademarks of RLS Global AB. Convatec and the Convatec logo are trademarks of the Convatec group of companies.

logo ;

References:

 

1. ChloraSolv® Instructions For Use. Version: 2021-09-06.

2. Data on file. RP-00008 Biological Evaluation.

3. Eliasson, B., Fagerdahl, A-M., Jönsson, A., Apelqvist, J. Debriding effect of amino acid-buffered hypochlorite on hard-to-heal wounds covered by devitalised tissue: pilot study. Journal of Wound Care (June 2021) 30:6.

4. ChloraSolv®, information for use sheet, 10703-ML VERSION: 2021-09-06.

5. Data on file. RP-00087 ChloraSolv Claims Verification.

6. Olausson S. Ahlenius M. Fast and complete eradication of biofilm by wound debridement gel. EWMA 2021.

7. Atkin L, Tickle J, Wilde K. Introducing ChloraSolv®: an innovative technology for debridement and wound bed preparation. J Wound Care 2022; 31 (Suppl 1): S1-23.

8. K. Bergqvist, et al, 2016. The role of chloramines in treatment of diabetic foot ulcers: an exploratory multi-centre randomised controlled trial, Clinical Diabetes and Endocrinology (2016) 2:6.

9. ChloraSolv® Wound Debridement Gel White Paper. SC-62121-GBL-ENG-v2. June 2023.

 

You are leaving convatec.com

This Internet site may provide links or references to other sites but Convatec have no responsibility for the content of such other sites and shall not be liable for any damages or injury arising from that content. Any links to other sites are provided as merely a convenience to the users of this Internet site.

Do you wish to continue?